ExodusPoint Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,185
Closed -$41K 1698
2024
Q3
$41K Buy
+3,185
New +$41K ﹤0.01% 1427
2024
Q2
Sell
-642
Closed -$200K 1646
2024
Q1
$200K Buy
642
+61
+10% +$19K ﹤0.01% 1233
2023
Q4
$152K Buy
+581
New +$152K ﹤0.01% 1246
2021
Q3
Sell
-631
Closed -$253K 2341
2021
Q2
$253K Buy
+631
New +$253K ﹤0.01% 1765
2020
Q3
Sell
-1,670
Closed -$947K 1962
2020
Q2
$947K Buy
+1,670
New +$947K 0.02% 752